Hyperleukocytosis associated with delayed presentation among patients with acute leukemia during the COVID-19 pandemic.
Autorzy:
Tedjaseputra A; The Alfred Hospital, Melbourne, Australia.; Monash Haematology, Melbourne, Australia.; St. Vincent's Hospital Melbourne, Melbourne, Australia.; Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Australia. Kuzich JA; Austin Health, Melbourne, Australia. Thiagarajah N; Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Australia. Teh TC; Eastern Health, Melbourne, Australia. McClelland J; St. Vincent's Hospital Melbourne, Melbourne, Australia. Rahman M; Western Health, Melbourne, Australia. Brook R; Northern Health, Melbourne, Australia. Chua CC; The Alfred Hospital, Melbourne, Australia.; Northern Health, Melbourne, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia. Ong DM; Western Health, Melbourne, Australia. Tan SY; St. Vincent's Hospital Melbourne, Melbourne, Australia. Filshie R; St. Vincent's Hospital Melbourne, Melbourne, Australia. Fong CY; Austin Health, Melbourne, Australia. Fedele P; Monash Haematology, Melbourne, Australia.; School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia. Bajel A; Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, Australia. Shortt J; Monash Haematology, Melbourne, Australia.; School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia. WeiAH; The Alfred Hospital, Melbourne, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Nov; Vol. 63 (11), pp. 2731-2734. Date of Electronic Publication: 2022 Jun 21.
New insights into the pathogenesis of Hermansky-Pudlak syndrome.
Autorzy:
Li W; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Center of Rare Diseases, National Center for Children's Health, Beijing, China.; MOE Key Laboratory of Major Diseases in Children, Capital Medical University, Beijing, China. Hao CJ; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Center of Rare Diseases, National Center for Children's Health, Beijing, China.; MOE Key Laboratory of Major Diseases in Children, Capital Medical University, Beijing, China. Hao ZH; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Center of Rare Diseases, National Center for Children's Health, Beijing, China.; MOE Key Laboratory of Major Diseases in Children, Capital Medical University, Beijing, China. Ma J; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Center of Rare Diseases, National Center for Children's Health, Beijing, China.; MOE Key Laboratory of Major Diseases in Children, Capital Medical University, Beijing, China. Wang QC; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Center of Rare Diseases, National Center for Children's Health, Beijing, China.; MOE Key Laboratory of Major Diseases in Children, Capital Medical University, Beijing, China. Yuan YF; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Center of Rare Diseases, National Center for Children's Health, Beijing, China.; MOE Key Laboratory of Major Diseases in Children, Capital Medical University, Beijing, China. Gong JJ; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Center of Rare Diseases, National Center for Children's Health, Beijing, China.; MOE Key Laboratory of Major Diseases in Children, Capital Medical University, Beijing, China. Chen YY; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Center of Rare Diseases, National Center for Children's Health, Beijing, China.; MOE Key Laboratory of Major Diseases in Children, Capital Medical University, Beijing, China. Yu JY; Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Center of Rare Diseases, National Center for Children's Health, Beijing, China.; MOE Key Laboratory of Major Diseases in Children, Capital Medical University, Beijing, China. WeiAH; Department of Dermatology, Tongren Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2022 May; Vol. 35 (3), pp. 290-302. Date of Electronic Publication: 2022 Feb 13.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
Effect of drug combination on tacrolimus target dose in renal transplant patients with different CYP3A5 genotypes.
Autorzy:
Zhang SF; School of Pharmacy, Shandong First Medical University, Taian, People's Republic of China.; Department of Pharmacy, Tai'an City Central Hospital, Taian, People's Republic of China. Tang BH; School of Pharmaceutical Science, Shandong University, Jinan, People's Republic of China. WeiAH; Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. Du Y; School of Pharmacy, Shandong First Medical University, Taian, People's Republic of China. Guan ZW; School of Pharmaceutical Science, Shandong University, Jinan, People's Republic of China. Li Y; Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University, Ji'nan, People's Republic of China.
Phase I trials of the lysine-specific demethylase 1 inhibitor, GSK2879552, as mono- and combination-therapy in relapsed/refractory acute myeloid leukemia or high-risk myelodysplastic syndromes.
Autorzy:
Roboz GJ; Weill Cornell Medicine and New York-Presbyterian Hospital, New York, NY, USA. Yee K; Princess Margaret Cancer Center, Toronto, ON, Canada. Verma A; Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY, USA. Borthakur G; MD Anderson Cancer Center, Houston, TX, USA. de la Fuente Burguera A; MD Anderson Cancer Center, Madrid, Spain. Sanz G; Department of Hematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain. Mohammad HP; GSK, Collegeville, PA, USA. Kruger RG; GSK, Collegeville, PA, USA. Karpinich NO; GSK, Collegeville, PA, USA. Ferron-Brady G; GSK, Collegeville, PA, USA. Acusta A; GSK, Collegeville, PA, USA. Del Buono H; GSK, Collegeville, PA, USA. Collingwood T; GSK, Collegeville, PA, USA. Ballas M; GSK, Collegeville, PA, USA. Dhar A; GSK, Collegeville, PA, USA. WeiAH; Alfred Hospital and Monash University, Melbourne, VIC, Australia.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Feb; Vol. 63 (2), pp. 463-467. Date of Electronic Publication: 2021 Dec 19.
Typ publikacji:
Clinical Trial, Phase I; Letter; Research Support, Non-U.S. Gov't
The effect of COVID-19-related changes on geographical outcomes in the 2021 dermatology residency match.
Autorzy:
Mulligan KM; Case Western Reserve University School of Medicine, Cleveland, OH, USA. Zheng DX; Case Western Reserve University School of Medicine, Cleveland, OH, USA. Narang J; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. Eversman A; Case Western Reserve University School of Medicine, Cleveland, OH, USA. Kalra MK; Case Western Reserve University School of Medicine, Cleveland, OH, USA. Morgan F; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. Obi EE; Case Western Reserve University School of Medicine, Cleveland, OH, USA. Osei-Koomson W; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. Russell ER; Case Western Reserve University School of Medicine, Cleveland, OH, USA. WeiAH; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA. Sharma TR; Case Western Reserve University School of Medicine, Cleveland, OH, USA.; Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Post-transplant maintenance therapy for MDS and AML: a bridge too far or the beginning of a new era?
Autorzy:
Loo S; Department of Clinical Hematology, Alfred Hospital, Melbourne, VIC, Australia. WeiAH; Australian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (13), pp. 3073-3077. Date of Electronic Publication: 2021 Aug 04.
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis.
Autorzy:
de Botton S; Departement d'hematologie, Institut Gustave Roussy, Villejuif, France. Brandwein JM; University of Alberta, Edmonton, Alberta, Canada. WeiAH; Alfred Hospital and Monash University, Melbourne, Australia. Pigneux A; CHU Bordeaux, Hôpital du Haut Lévêque, Bordeaux, France. Quesnel B; CHU Lille, Lille, France. Thomas X; Centre Hospitalier Lyon Sud, Pierre Bénite, France. Legrand O; APHP, Hôpital Saint-Antoine, Paris, France. Recher C; CHU de Toulouse, Université de Toulouse III Paul Sabatier, Toulouse, France. Chantepie S; CHU de Caen, Caen, France. Hunault-Berger M; CHU Angers, Angers, France. Boissel N; Hôpital Saint-Louis, Paris, France. Nehme SA; Celgene International, a Bristol Myers Squibb Company, Boudry, Switzerland. Frattini MG; Bristol Myers Squibb, Summit, New Jersey, USA. Tosolini A; Bristol Myers Squibb, Summit, New Jersey, USA. Marion-Gallois R; Bristol Myers Squibb, Summit, New Jersey, USA. Wang JJ; Bristol Myers Squibb, Summit, New Jersey, USA. Cameron C; Cornerstone Research Group, Burlington, Ontario, Canada. Siddiqui M; Cornerstone Research Group, Burlington, Ontario, Canada. Hutton B; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Milkovich G; RJM Group LLC, Crown Point, Indiana, USA. Stein EM; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Sep; Vol. 10 (18), pp. 6336-6343. Date of Electronic Publication: 2021 Aug 24.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial.
Autorzy:
Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. . Roboz GJ; Weill Cornell Medicine, New York, NY, USA.; New York Presbyterian Hospital, New York, NY, USA. WeiAH; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Australia.; Australian Centre for Blood Diseases, Monash University, Melbourne, Australia. Döhner H; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany. Pocock C; Kent & Canterbury Hospital, Canterbury, UK. Selleslag D; AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium. Montesinos P; Hospital Universitari i Politècnic La Fe, Valencia, Spain. Sayar H; Indiana University Cancer Center, Indianapolis, IN, USA. Musso M; La Maddalena - Casa di Cura, Palermo, Italy. Figuera-Alvarez A; Hospital Universitario de La Princesa, Madrid, Spain. Safah H; Tulane University Health Science Center, New Orleans, LA, USA. Tse W; University of Louisville School of Medicine, Louisville, KY, USA. Sohn SK; Kyungpook National University Hospital, Daegu, Korea. Hiwase D; Royal Adelaide Hospital, Adelaide, Australia. Chevassut T; Brighton and Sussex Medical School, Brighton, UK. Pierdomenico F; Portuguese Institute of Oncology Lisbon, Lisbon, Portugal. La Torre I; Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland. Skikne B; University of Kansas Medical Center, Kansas City, KS, USA.; Bristol Myers Squibb, Princeton, NJ, USA. Bailey R; Bristol Myers Squibb, Princeton, NJ, USA. Zhong J; Bristol Myers Squibb, Princeton, NJ, USA. Beach CL; Bristol Myers Squibb, Princeton, NJ, USA. Dombret H; Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France.; Institut de Recherche Saint-Louis, Université de Paris, Paris, France.
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2021 Aug 28; Vol. 14 (1), pp. 133. Date of Electronic Publication: 2021 Aug 28.
Identifying Key Genetic Regions for Cell Sheet Morphogenesis on Chromosome 2L Using a Drosophila Deficiency Screen in Dorsal Closure.
Autorzy:
Fogerson SM; Biology Department, Duke University, Durham, NC, 27708 . Mortensen RD; Biology Department, Duke University, Durham, NC, 27708. Moore RP; Department of Pharmacology, University of North Carolina, Chapel Hill, NC, 27599.; Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill, 27599, USA and North Carolina State University, Raleigh, NC, 27695. Chiou HY; Biology Department, Duke University, Durham, NC, 27708. Prabhu NK; Biology Department, Duke University, Durham, NC, 27708. WeiAH; Biology Department, Duke University, Durham, NC, 27708. Tsai D; Biology Department, Duke University, Durham, NC, 27708. Jadi O; Biology Department, Duke University, Durham, NC, 27708. Andoh-Baidoo K; Biology Department, Duke University, Durham, NC, 27708. Crawford J; Biology Department, Duke University, Durham, NC, 27708. Mudziviri M; Biology Department, Duke University, Durham, NC, 27708. Kiehart DP; Biology Department, Duke University, Durham, NC, 27708 .
Pokaż więcej
Źródło:
G3 (Bethesda, Md.) [G3 (Bethesda)] 2020 Nov 05; Vol. 10 (11), pp. 4249-4269. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Androgens stimulate erythropoiesis through the DNA-binding activity of the androgen receptor in non-hematopoietic cells.
Autorzy:
McManus JF; Central Clinical School, Australian Centre for Blood Diseases, Monash University, Melbourne, Vic., Australia.; Human Molecular Pathology, Alfred Pathology Service, Alfred Health, Melbourne, Vic., Australia. Nguyen NN; Cartherics Pty Ltd, Melbourne, Vic., Australia.; Hudson Institute of Medical Research, Melbourne, Vic., Australia. Davey RA; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Vic., Australia. MacLean HE; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Vic., Australia. Pomilio G; Central Clinical School, Australian Centre for Blood Diseases, Monash University, Melbourne, Vic., Australia.; Department of Clinical Haematology, Alfred Health, Melbourne, Vic., Australia. McCormack MP; Central Clinical School, Australian Centre for Blood Diseases, Monash University, Melbourne, Vic., Australia. Chiu WS; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Vic., Australia. WeiAH; Central Clinical School, Australian Centre for Blood Diseases, Monash University, Melbourne, Vic., Australia.; Department of Clinical Haematology, Alfred Health, Melbourne, Vic., Australia. Zajac JD; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Vic., Australia. Curtis DJ; Central Clinical School, Australian Centre for Blood Diseases, Monash University, Melbourne, Vic., Australia.; Department of Clinical Haematology, Alfred Health, Melbourne, Vic., Australia.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2020 Sep; Vol. 105 (3), pp. 247-254. Date of Electronic Publication: 2020 May 15.
Correction: Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.
Treatment practice and outcomes in FLT3- mutant acute myeloid leukemia in the pre-midostaurin era: a real-world experience from Australian tertiary hospitals.
Autorzy:
Chua CC; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, Australia. Grigg A; Department of Clinical Haematology, Austin Health, Heidelberg, Australia. Singh J; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, Australia. Droogleever MP; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, Australia.; Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Zhang L; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, Australia. Lim A; Department of Clinical Haematology, Austin Health, Heidelberg, Australia. Fong CY; Department of Clinical Haematology, Austin Health, Heidelberg, Australia. Ting SB; Department of Haematology, Eastern Health and Monash University, Box Hill, Australia. Schwarer A; Department of Haematology, Eastern Health and Monash University, Box Hill, Australia. Tiong IS; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, Australia. WeiAH; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, Australia.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Apr; Vol. 61 (4), pp. 848-854. Date of Electronic Publication: 2019 Nov 21.
The Bio-Tribological Effect of Poly-Gamma-Glutamic Acid in the Lysozyme-Ionic Contact Lens System.
Autorzy:
Su CY; Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, 1, Sec. 3, Zhongxiao E. Rd., Taipei 10608, Taiwan. Yeh LK; Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou. No. 5, Fuxing St., Taoyuan 333, Taiwan.; College of Medicine, Chang Gung University, No.259, Wenhua 1st Rd., Taoyuan 333, Taiwan. Lai CC; Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou. No. 5, Fuxing St., Taoyuan 333, Taiwan.; College of Medicine, Chang Gung University, No.259, Wenhua 1st Rd., Taoyuan 333, Taiwan. Dubuisson M; Anton Paar TriTec SA, Les Vernets 6, 2035 Corcelles-Cormondrèche, Switzerland. Tsao YF; Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, 1, Sec. 3, Zhongxiao E. Rd., Taipei 10608, Taiwan. Tseng CL; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, No. 250, Wu-Hsing St., Taipei 110, Taiwan. Fang AH; Department of Chemical Engineering and Biotechnology, National Taipei University of Technology, 1, Sec. 3, Zhongxiao E. Rd., Taipei 10608, Taiwan.; Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes. No. 35, Keyan Road, Zhunan Town, Miaoli County 35053, Taiwan.
Pokaż więcej
Źródło:
Polymers [Polymers (Basel)] 2020 Jan 07; Vol. 12 (1). Date of Electronic Publication: 2020 Jan 07.
Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia.
Autorzy:
Dombret H; Department of Hematology, Hôpital Saint-Louis (Assistance Publique - Hôpitaux de Paris) and University Paris Diderot , Paris , France. Topp MS; Klinik und Poliklinik II, Universitätsklinikum Würzburg , Würzburg , Germany. Schuh AC; Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network , Toronto , Canada. WeiAH; Department of Haematology, Alfred Hospital and Monash University , Melbourne , Australia. Durrant S; Bone Marrow Transplant Unit, Royal Brisbane Hospital , Herston , Australia. Bacon CL; Haematology Department, St. James's Hospital , Dublin , Ireland. Tran Q; Amgen Inc , Thousand Oaks , CA , USA. Zimmerman Z; Amgen Inc , Thousand Oaks , CA , USA. Kantarjian H; Department of Leukemia, University of Texas M.D. Anderson Cancer Center , Houston , TX , USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Sep; Vol. 60 (9), pp. 2214-2222. Date of Electronic Publication: 2019 Apr 05.
Identifying Genetic Players in Cell Sheet Morphogenesis Using a Drosophila Deficiency Screen for Genes on Chromosome 2R Involved in Dorsal Closure.
Autorzy:
Mortensen RD; Biology Department, Duke University, Durham, NC, 27708, USA. Moore RP; Biology Department, Duke University, Durham, NC, 27708, USA. Fogerson SM; Biology Department, Duke University, Durham, NC, 27708, USA. Chiou HY; Biology Department, Duke University, Durham, NC, 27708, USA. Obinero CV; Biology Department, Duke University, Durham, NC, 27708, USA. Prabhu NK; Biology Department, Duke University, Durham, NC, 27708, USA. WeiAH; Biology Department, Duke University, Durham, NC, 27708, USA. Crawford JM; Biology Department, Duke University, Durham, NC, 27708, USA. Kiehart DP; Biology Department, Duke University, Durham, NC, 27708, USA .
Pokaż więcej
Źródło:
G3 (Bethesda, Md.) [G3 (Bethesda)] 2018 Jul 02; Vol. 8 (7), pp. 2361-2387. Date of Electronic Publication: 2018 Jul 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Enhanced differentiation of human amniotic fluid-derived stem cells into insulin-producing cells in vitro.
Autorzy:
Mu XP; Department of Central Laboratory, China-Japan Union Hospital of Jilin University, Changchun, China. Ren LQ; College of Pharmacy, Jilin University, Changchun, China. Yan HW; College of Pharmacy, Jilin University, Changchun, China. Zhang XM; College of Pharmacy, Jilin University, Changchun, China. Xu TM; The Second Affiliated Hospital of Jilin University, Changchun, China. WeiAH; College of Pharmacy, Jilin University, Changchun, China. Jiang JL; Department of Central Laboratory, China-Japan Union Hospital of Jilin University, Changchun, China.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2017 Jan; Vol. 8 (1), pp. 34-43. Date of Electronic Publication: 2016 Jun 30.
Mutation of SLC35D3 causes metabolic syndrome by impairing dopamine signaling in striatal D1 neurons.
Autorzy:
Zhang Z; State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China ; Graduate School of Chinese Academy of Sciences, Beijing, China. Hao CJ; State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China ; Graduate School of Chinese Academy of Sciences, Beijing, China ; Reproductive and Genetic Center, National Research Institute for Family Planning, Beijing, China. Li CG; The Affiliated Hospital of Qingdao University Medical College, Qingdao, China. Zang DJ; State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. Zhao J; Model Animal Research Center, Nanjing University, Nanjing, China. Li XN; Nanjing Children's Hospital, Nanjing Medical University, Nanjing, China. WeiAH; Beijing Tongren Hospital, Capital Medical University, Beijing, China. Wei ZB; State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China ; Graduate School of Chinese Academy of Sciences, Beijing, China. Yang L; State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. He X; State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China. Zhen XC; Department of Pharmacology, Soochow University College of Pharmaceutical Sciences, Suzhou, China. Gao X; Model Animal Research Center, Nanjing University, Nanjing, China. Speakman JR; State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China ; Institute of Biological and Environmental Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom. Li W; State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China.
Pokaż więcej
Źródło:
PLoS genetics [PLoS Genet] 2014 Feb 13; Vol. 10 (2), pp. e1004124. Date of Electronic Publication: 2014 Feb 13 (Print Publication: 2014).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
